Drugs with this side effect
- 4-PBA: common
- 5-ASA: postmarketing
- 8-MOP: postmarketing
- A77 1726
- ALX 111
- Azarga: common
- CAS 76095-16-4
- CAS 76420-72-9: postmarketing
- Cancidas
- Colimycin M
- D-penicillamine
- Enfuvirtide
- FK463
- FP-CIT: uncommon
- Fe(III: postmarketing, 0% - 7.9%
- Gd-DTPA
- Gd-EOB-DTPA
- K779: 1% - 24%
- L-Dmp
- LY146032: 0% - 2.6%
- Lantus
- LiOH
- Lisinopril: postmarketing, uncommon
- Lovaza: 2.7% - 4%
- Lu AA21004
- MK-462: postmarketing
- MnDPDP
- N-carbamylglutamate
- Nafarelin
- Optison: uncommon
- Photofrin II: common
- Prednefrin
- Romidepsin: 0% - 39.8%
- SU5416
- Sativex
- SonoVue
- Stalevo 50
- Supremon: 1.79%
- Triptorelin
- acamprosate: frequent
- acetazolamide
- acitretin: postmarketing, 1-10%
- acyclovir
- afatinib: common
- alendronate: postmarketing, 0.1% - 0.5%
- allopurinol
- almotriptan: rare
- amiodarone
- amlodipine
- amlodipine besylate
- amoxicillin: 5%
- amphetamine
- anastrozole
- anthracycline
- apraclonidine: postmarketing, 3%
- aprepitant
- aripiprazole
- articaine
- asenapine: 3%
- atazanavir: uncommon
- atomoxetine
- atorvastatin: postmarketing
- atovaquone: 3% - 13%
- auranofin
- axitinib: 0% - 11%
- azelastine: 2.41% - 3.73%
- azithromycin: postmarketing, 0% - 2.5%
- baclofen: rare
- bendamustine: 0%
- betaxolol: postmarketing
- bexarotene
- bisoprolol
- boceprevir: very common, 11% - 16%
- bortezomib: 0% - 13%
- bosutinib
- brimonidine: uncommon
- brinzolamide: postmarketing, common, 4.4% - 6%
- budesonide
- buprenorphine
- bupropion: 0.3% - 4%
- butenafine
- cabazitaxel: 0%
- cabozantinib: 0% - 34%
- capecitabine: 1% - 14%
- capsaicin: uncommon
- captopril
- carbamazepine: very rare
- carboplatin: 1%
- carnitine: 2% - 9%
- carteolol
- cefditoren
- cefepime
- cefpodoxime
- ceftobiprole: 5.6%
- ceftriaxone
- celecoxib
- cephem
- cerivastatin
- cetirizine: postmarketing
- cevimeline
- chlorhexidine
- chlorhexidine gluconate
- ciclesonide: 0.2% - 0.4%
- cidofovir
- cilazapril
- ciprofloxacin: common, 5%
- citalopram: infrequent, uncommon, common, frequent
- clarithromycin: postmarketing, uncommon, 3% - 15%
- clindamycin
- clindamycin phosphate
- clomipramine: common, 4% - 8%
- cobicistat: common
- colestimide: uncommon
- copolymer 1
- crizotinib: 0% - 26%
- cyclobenzaprine: 6%
- cyclophosphamide: postmarketing
- d-telaprevir: common, 3%
- dantrolene
- darifenacin
- darunavir
- dasatinib
- delavirdine
- deprenyl: frequent
- desvenlafaxine: 1% - 2%
- diatrizoate
- diazepam
- diclofenac: very rare, postmarketing, 0% - 3.81%
- diltiazem
- dipyridamole: 0.1%
- docetaxel: postmarketing, rare, 0% - 29.5%
- dolasetron
- dorzolamide
- doxazosin
- doxepin: infrequent, 0.299% - 1.52%
- doxorubicin: common
- dronedarone
- duloxetine: postmarketing, uncommon, frequent, 3%
- efavirenz
- eletriptan: infrequent
- elvitegravir: uncommon
- emedastine
- entacapone: 1%
- eribulin
- ertapenem
- esmolol
- esomeprazole magnesium: postmarketing, 6.6%
- estradiol: postmarketing
- etodolac: postmarketing
- etoposide: 6%
- etoposide phosphate: 6%
- etoricoxib
- everolimus: common, very common, 0% - 19%
- exenatide: postmarketing, uncommon
- famotidine
- felbamate: 6.1%
- fentanyl: 0% - 14.3%
- ferumoxytol: postmarketing
- fesoterodine
- fidaxomicin
- flecainide
- florbetapir: uncommon
- fluconazole: postmarketing, uncommon, 0% - 1.3%
- fludrocortisone acetate
- flunisolide
- fluocinolone acetonide
- fluorescein: postmarketing, common
- fluorometholone
- fluoxetine: common, frequent
- fluvastatin: postmarketing
- fluvoxamine: postmarketing, 1% - 3%
- formoterol: very rare
- fosaprepitant
- fosaprepitant dimeglumine
- fosinopril
- fosinoprilat
- fosphenytoin: frequent, 0% - 3.3%
- frovatriptan: infrequent
- gabapentin: infrequent
- gadobenate dimeglumine: 3.3%
- gadobutrol
- gadodiamide
- gadofosveset
- gadolinium: 0.4% - 6.2%
- gadopentetate
- gadoteridol: 1.43%
- gadoversetamide: 2.53% - 6.2%
- galantamine: postmarketing
- ganciclovir
- gatifloxacin: 1.4%
- gemfibrozil
- gemifloxacin: 0.3% - 1.9%
- glycopyrrolate
- granisetron
- guanfacine: postmarketing
- histamine
- hydrochlorothiazide
- hydromorphone
- hydroxybutyrate
- ibandronate
- iloprost: postmarketing
- imatinib: common, 0% - 15%
- indapamide
- indinavir: 1.2% - 19.1%
- insulin detemir
- iodixanol: 3.4% - 14.9%
- iohexol
- iopamidol
- iopromide
- ioversol
- ioxilan
- ipratropium bromide: 1.2% - 3.7%
- irbesartan: postmarketing, rare
- irbesartan-hydrochlorothiazide
- iron sucrose: 7.7%
- itraconazole: postmarketing, 1%
- ketoconazole
- ketoprofen
- ketorolac tromethamine: postmarketing
- lamivudine
- lamotrigine: infrequent
- lansoprazole: postmarketing, 5%
- lasofoxifene: rare
- leflunomide
- lenalidomide: postmarketing, common, 15.3%
- lercanidipine
- letrozole: uncommon
- leucovorin
- lidocaine
- linezolid: 0.2% - 2%
- lithium
- lithium carbonate
- lomefloxacin: postmarketing
- lormetazepam
- losartan: postmarketing
- lovastatin: postmarketing
- loxapine: very common, 14%
- lubiprostone
- maprotiline
- medroxyprogesterone acetate
- meloxicam
- memantine
- meropenem
- mesna: postmarketing
- metformin: common, 3%
- methazolamide
- metoprolol: postmarketing
- metronidazole: very rare, postmarketing, 0% - 9%
- miconazole: 0% - 4.1%
- milnacipran
- mirtazapine
- mitotane
- modafinil
- mometasone furoate
- morphine
- moxifloxacin: 1%
- mupirocin: 0.8% - 3%
- mycophenolate mofetil
- n-3 PUFA: 4%
- naltrexone
- nefazodone
- nelarabine: 0% - 3%
- nicotine: 1.9%
- nifedipine
- nilotinib: common
- nisoldipine
- norfloxacin: postmarketing
- ofloxacin: postmarketing, 7%
- olanzapine: infrequent
- olopatadine: postmarketing
- omeprazole: postmarketing, rare, 6.6% - 15%
- oxaliplatin: very common, 0% - 8%
- oxaprozin
- oxcarbazepine: 0% - 5%
- oxybutynin: 1.1% - 1.6%
- oxycodone
- paclitaxel: common
- paliperidone: very rare, postmarketing
- palonosetron
- pamidronate: postmarketing, 0% - 3%
- pantoprazole: postmarketing
- paricalcitol: 2%
- paroxetine: common, 2%
- pazopanib: 0% - 28%
- pemetrexed: 6%
- penciclovir: 0.2%
- pentazocine
- pergolide: infrequent, 1.6%
- perindopril
- phenylbutyric acid
- phenytoin: frequent, 0% - 3.3%
- pilocarpine
- pirfenidone
- posaconazole
- pramipexole
- pravastatin: postmarketing
- prednisolone acetate
- pregabalin: infrequent
- propafenone: postmarketing, 5.56% - 22.1%
- propofol
- propylthiouracil
- quetiapine: infrequent, 1%
- rabeprazole: 14%
- raltegravir
- raltitrexed: 2-3%
- ramelteon: 2%
- ramipril
- ramiprilat
- rasagiline: infrequent
- reboxetine: 1.59%
- regadenoson: common, 5% - 7%
- ribavirin: common, 1% - 8%
- rifabutin: 3%
- riluzole
- rimexolone
- risperidone: postmarketing
- ritonavir: 5.4% - 17.2%
- rivastigmine: infrequent
- rizatriptan: postmarketing
- rofecoxib
- roflumilast
- ropinirole: infrequent
- salbutamol: postmarketing
- salicylate
- salmon calcitonin acetate: common
- saquinavir: common
- sertraline: postmarketing
- sevoflurane
- sibutramine
- simvastatin
- sodium ferric gluconate
- solifenacin
- sorafenib: postmarketing, common
- sotalol
- sparfloxacin: postmarketing, 1.4%
- stavudine
- sugammadex
- sumatriptan: infrequent
- sunitinib
- tacrolimus
- tamoxifen
- technetium-99m: 6.65% - 19.2%
- telavancin: very common, 7% - 33%
- telithromycin: 1.1% - 3.6%
- telmisartan: rare
- temozolomide: common, 0% - 6.25%
- temsirolimus
- terazosin
- terbinafine: postmarketing, common, 0% - 2.8%
- testosterone: postmarketing, 2%
- thalidomide
- thymidine
- tiagabine: infrequent
- tigecycline
- tinidazole
- tobramycin: common, 0.5% - 6.6%
- tolcapone
- tolvaptan: uncommon
- topiramate: very rare, postmarketing, 0% - 15.4%
- trabectedin
- tramadol: postmarketing, uncommon, 3.72%
- tramazoline
- trametinib
- trandolapril
- travoprost: rare, uncommon
- trazodone
- triamcinolone: 5% - 7.8%
- triamcinolone acetonide
- triazolam
- trospium chloride
- trovafloxacin
- v 1784: postmarketing
- valdecoxib
- valganciclovir
- valproate
- valsartan
- vandetanib: 0% - 8%
- varenicline: 5% - 8%
- vemurafenib: postmarketing, 0% - 14%
- venlafaxine: frequent
- vernakalant: very common
- vilazodone: infrequent
- vinflunine
- vismodegib: 55.1% - 57.2%
- voriconazole: rare, uncommon
- vorinostat
- warfarin
- zalcitabine
- zaleplon: frequent
- ziconotide: 5%
- zidovudine: postmarketing, rare, 5%
- zidovudine/lamivudine
- zoledronic acid: postmarketing, uncommon
- zolmitriptan
- zolpidem: infrequent
- zonisamide: 2%
- zopiclone
|
Drugs with this indication
|
